Prognostic value of cyclin E and p53 expression in gastric carcinoma
β Scribed by Teruyuki Sakaguchi; Akihiko Watanabe; Hidetomo Sawada; Yukishige Yamada; Jun Yamashita; Masahiko Matsuda; Masakazu Nakajima; Takeshi Miwa; Tomoko Hirao; Hiroshige Nakano
- Publisher
- John Wiley and Sons
- Year
- 1998
- Tongue
- English
- Weight
- 236 KB
- Volume
- 82
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
β¦ Synopsis
With regard to prognosis, patients whose tumors had both First Department of Surgery, Nara Medical Unistrong positivity for cyclin E and positivity for p53 had significantly poorer prognosis. versity, Nara, Japan.
In multivariate analysis, the combined variable of cyclin E and p53 was an independent prognostic indicator together with serosal invasion and tumor size.
CONCLUSIONS.
These data suggest the cyclin E expression correlates with p53 expression and may contribute to the progression of gastric carcinoma. The combined variable of cyclin E and p53 expression could be a useful prognostic indicator in patients with gastric carcinoma.
π SIMILAR VOLUMES
The presence of the nuclear phosphoprotein p53 was investigated in a series of 120 consecutive gastric carcinomas. This immunohistochemical study on formalin-fixed, paraffin-embedded material found p53 expression in 43 per cent ( ~5 1 ) of carcinomas using a monoclonal antibody (DO-l), whereas no im
Malignant uveal melanoma is the commonest primary intraocular tumour in adults. It metastasizes frequently and 50% of patients die within 10 years of diagnosis. The expression of cyclin D1, p53, and MDM2 in uveal melanoma and their relationship to metastasis-free 5-year survival was determined, in o
## Background and objectives: It is generally accepted that the overexpression of p53 protein is associated with poor prognosis in breast, colorectal, and other types of cancer. however, the prognostic significance of p53 aberrations in esophageal squamous cell carcinoma has yet to be determined. w
## BACKGROUND. Natural killer (NK) cells are a group of effector cells that act nonspecifically against tumor cells. The correlation between intratumoral NK cell infiltration and clinicopathologic features remains unclear.
Many studies have tried to discriminate malignant from benign phaeochromocytomas, but until now no widely accepted histological, immunohistochemical, or molecular methods have been available. In this study of 29 malignant and 85 benign phaeochromocytomas from 102 patients, immunohistochemistry was p